Clinical features of childhood acute myeloid leukaemia with specific gene rearrangements [1]

Leukemia

Volumn 18, Issue 8, 2004, Pages 1427-1429

  Frascella, Emanuela ^a   Rondelli, R ^b   Pigazzi, M ^a   Zampieron, C ^a   Fagioli, F ^c   Favre, C ^d   Lippi, A A ^e   Locatelli, F ^f   Luciani, M ^g   Menna, G ^h   Micalizzi, C ⁱ   Rizzari, C ^j   Testi, A M ^k   Pession, A ^b   Basso, G ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITY OF PISA   (Italy)

^e UNIVERSITY OF FLORENCE   (Italy)

^f UNIVERSITY OF PAVIA   (Italy)

^g BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^h SANTOBONO PAUSILIPON CHILDREN S HOSPITAL   (Italy)

ⁱ G GASLINI INSTITUTE   (Italy)

^j University of Monza   (Italy)

^k SAPIENZA UNIVERSITY OF ROME   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; CYTARABINE;

ACUTE GRANULOCYTIC LEUKEMIA; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME INVERSION; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 8; CHROMOSOME TRANSLOCATION 9; CLINICAL FEATURE; CYTOGENETICS; FUSION GENE; GENE FREQUENCY; GENE REARRANGEMENT; GENETIC TRANSCRIPTION; HUMAN; LETTER; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 4344635648     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403410     Document Type: Letter

References (8)

1. Forestier E, Heim S, Blennow E, Borgstrom G, Holmgren G, Heinonen K et al. Cytogenetic abnormalities in childhood acute myeloid leukaemia: a Nordic series comprising all children enrolled in the NOPHO-93-AML trial between 1993 and 2001. Br J Haematol 2003; 121: 566-577.
2. Biondi A, Rovelli A, Cantù-Rajnoldi A, Fenu S, Basso G, Luciano A et al. Acute promyelocytic leukaemia in children: experience of the Italian Pediatric Hematology and Oncology Group (AIEOP). Leukemia 1994; 8: 1264-1268.
3. Martinez-Climent JA, Lane NJ, Rubin CM, Morgan E, Johnstone HS, Mick R et al. Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo. Leukemia 1995; 9: 95-101.
4. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into MRC 10 trial. Blood 1998; 92: 2322-2333.
5. Raimondi SC, Chang MN, Ravindranath Y, Behm FG, Gresik MV, Steuber CP et al. Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative Pediatric Oncology Group Study - POG8821. Blood 1999; 94: 3707-3716.
6. Krauter J, Peter W, Pascherberg U, Heinze B, Bergmann L, Hoelzer D et al. Detection of karyotypic aberrations in acute myeloblastic leukaemia: a prospective comparison between PCR/HSH and standard cytogenetics in 140 patients with de novo AML. Br J Hematol 1998; 103: 72-78.
7. Rowe D, Cotterill SJ, Ross FM, Bunyan DJ, Vickers SJ, Bryon J et al. Cytogenetically cryptic AML1-ETO and CBFβ-Myh11 gene rearrangements: incidence in 412 case of acute myeloid leukaemia. Br J Haematol 2000; 111: 1051-1056.
8. Byrd JC, Dodge RK, Carrol A, Baer MR, Edward C, Stamberg J et al. Patients with t(8;21)(q22;q22) and acute myeloid leukaemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered. J Clin Oncol 1999; 17: 3767-3775.